During the past decade, Neuropsychiatric Associates conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuropsychiatric Associates" #1 sponsor was "Shire" with 5 trials, followed by "Sunovion" with 5 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuropsychiatric Associates" #1 collaborator was "Purdue Pharma LP" with 1 trials as a collaborator, "Purdue Pharma, Canada" with 1 trials as a collaborator, "Shire" with 1 trials as a collaborator and "The Emmes Company, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Neuropsychiatric Associates" are "ADHD" (4 trials), "Binge Eating Disorder" (4 trials), "Adult Attention Deficit Hyperactivity Disorder" (3 trials), "Attention Deficit Hyperactivity Disorder" (3 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials). Many other conditions were trialed in "Neuropsychiatric Associates" in a lesser frequency.

Most popular intervention types in "Neuropsychiatric Associates" are "Drug" (27 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Dasotraline" (4 trials), "AVP-786" (2 trials), "BMS-820836" (2 trials) and "Aripiprazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuropsychiatric Associates" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Neuropsychiatric Associates". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Neuropsychiatric Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neuropsychiatric Associates, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".